Cellbricks

Our leadership team is excited to kick off our trip to Cambridge, MA! Next week, we’ll be in Boston connecting with partners, peers, and investors, and exploring new opportunities. If you'd like to meet with us and catch up on our latest progress, feel free to reach out directly. And be sure to stay tuned - we’ll be sharing some exciting updates in the coming days! Alexander Leutner | Simon MacKenzie | Joachim von Arnim | Alexander Thomas | Alicia Ruppelt | Tobias Lam #Cellbricks #TissueTherapeutics #RegenerativeMedicine #Boston #CambridgeMA

Meet us at #BIOEurope 2024 and talk with us about our live-saving tissue therapeutics and how we are making cell therapies implantable. Our COO, Simon MacKenzie, will be on-site for one-to-one partnering meetings and to catch up on latest industry trends, network with peers, and share insights on our tissue therapeutics programs. You can also meet with us at the 🇩🇪 German Pavilion.   ➡️ Reach out to Simon directly (here or through the partnering platform) to set up a meeting and explore potential collaborations or partnership opportunities.    #TissueTherapeutics #MakingCellTherapyImplantable #Biofabrication #Cellbricks #BioEurope #GermanPavillion

Catch us in Manchester, NH, tomorrow. Joachim von Arnim, chief strategy officer, is pitching at the BioFab Startup Lab Investment Summit in the heart of ReGen Valley, a thriving innovation hub at the forefront of biofabrication and regenerative therapy. This annual summit hosted by Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA is a powerful convergence of entrepreneurship and investment, where visionary startups and leading professionals come together to shape the future of healthcare. #BioFabUSA #Cellbricks #TissueTherapeutics    #BioFabSummit #RegenerativeMedicine 

Networking at the MESA is an important date on our calendar! Our COO, Simon MacKenzie, will be in Phoenix, Arizona from October 7-9 to catch up on all the latest industry trends, network with peers, and share insights on our tissue therapeutics programs. ➡️ Reach out to Simon to set up a meeting and explore potential collaborations or partnership opportunities. #TissueTherapeutics #MakingCellTherapyImplantable #OnTheMesa #Cellbricks #CGMesa24

Cellbricks is excited to engage in the important "potentials for the future" discussion with Joachim von Arnim as panelist at the renowned #InnoNation Festival organized by BDI - Bundesverband der Deutschen Industrie e.V.!    Innovators from business, science, politics, and society will come together for deep-dive discussions on one question: How can Germany become an #InnoNation?    Join for our interactive Biotech/Bionic panel, where startups will pitch their transformative projects. These pitches offer a glimpse into cutting-edge developments that could redefine the BioTech industry, thereby the future of health and economic progress. Afterward, we'll discuss key challenges and opportunities, including funding, research support, and regulatory issues for Biotech Startups.    We are looking forward to sharing the stage with Simon Fallais, PhD | CDL Therapeutics GmbH, Jens Klein | Insempra, Konstantin Matentzoglu | Polpharma Biologics, Steffen Ganders | German Bionic and moderator, Dr. Thorsten Lambertus | ESMT Berlin DEEP. Supported by: Roland Berger, Boehringer Ingelheim, Bechtle, Dassault Systèmes, DHL, Nokia, OHB SE, QUTAC, Siemens, Die Autobahn GmbH des Bundes, Infineon Technologies, Infosys Consulting, SAP, of Unicorns&Lions, econsense - Forum for Sustainable Development of German Business e.V., #SheTransformsIT, Wissensfabrik. #InnoNation #Cellbricks #Innovation #TissueTherapeutics

We are excited to share that we have been honored with the Berlin Economic Award 2024! This award recognizes companies that contribute to Berlin's vibrant entrepreneurial ecosystem - from small and mid-sized businesses to dynamic start-ups driving innovation and change.    A huge thank you to Franziska Giffey (Senator for Economic Affairs, Energy and Public Enterprises), Ute Weiland (President, VBKI), and Joachim Spitzley (Initiator, Made in Berlin) for this kind recognition. We also congratulate our fellow award winners, Walter Confiserie and eduBITES - it was a pleasure sharing the stage with you.    A special shoutout to Verlag Der Tagesspiegel, Verein Berliner Kaufleute und Industrieller (VBKI), and Made in Berlin for hosting such an encouraging event. We are grateful being part of this amazing community and look forward to what the future holds! 📸  Tagesspiegel Berlinpreis für Wirtschaft 2024 (c) Marie Staggat #BerlinPreisFürWirtschaft #Tagesspiegel #VBKI #Cellbricks #Entrepreneurship #BerlinBusiness #TissueTherapeutics #TissueEngineering #FutureOfMedicine #ThankYou

Did you see that #BreakingLab, one of Germany's leading science channels, has visited us recently? The channel presents complex technologies, explaining them in simple words and making breakthrough approaches comprehensible to everyone. They've created an insightful clip about Cellbricks ' technology and our mission of developing life-saving tissue therapeutics for millions of patients worldwide. A big shoutout to Jacob Beautemps and his fabulous and professional team for their great work, and kudos to our team members, Alicia Ruppelt, Tobias Lam and Alexander Leutner, performing in front of the camera! Special thanks to SPRIND - Bundesagentur für Sprunginnovationen, Germany's Federal Agency for Disruptive Innovation, for facilitating this collaboration. 🎥 Watch the documentary here: https://lnkd.in/dprs72MV P.S.: Though audio is German, English subtitles can be selected. #BreakingLab #TissueTherapeutics #ScienceCommunication #SPRIND #Cellbricks #FutureOfMedicine 

What does it take to create Europe's next globally leading biotech ecosystem, covering every step from groundbreaking research to successful commercialisation? This was the leading question at this year’s fireside panel discussion at the #DRFZBerlinSymposium2024.     Key takeaways from the panel discussion: Strong Consensus: Europe has the huge potential conducting groundbreaking research.      Issue: A significant gap exists in translating research from the lab to the clinic, especially due to complex regulatory frameworks.      Recommendation: Policymakers must simplify regulatory frameworks and provide clearer guidance to accelerate the path of new therapies to patients.     Thanks for this great exchange between our Joachim von Arnim and Eicke Latz (German Rheumatology Research Center) | Stefan Miltenyi (Miltenyi Biotec) | Luke O'Neill (Trinity College Dublin) | Jan-Philipp Kruse (Bayer) | Dr. Thorsten Lambertus (DEEP - ESMT Berlin) as well as moderator Marco Janezic (Blue Ribbon Partners)     #TissueTherapeutics #Cellbricks #Charité #MaxPlanckSociety #Ecosystem 

An exciting week ahead: Cellbricks will be presenting at #TERMIS2024 World Congress in Seattle from June 25-28! Join us for our poster presentation on light-based 3D-bioprinting of vascularised fatty tissue for breast reconstruction. Léa Pourchet, Ph.D., our Senior Tissue Engineer, is eager to connect with you and share our latest advancements in tissue therapeutics. Details: Poster session III, C1, Thursday, June 27 We are looking forward to lively discussions! #TERMIS2024 #RegenerativeMedicine #TissueEngineering #3DBioprinting #Cellbricks #TissueTherapeutics

We're hiring – SENIOR LIVER CELL BIOLOGIST! #JoinOurTeam Cellbricks seeks an experienced liver cell biologist to join our Liver Tissue Therapeutics Program. In this role, you'll pioneer methods for scalable liver cell delivery and integrate them into our 3D-bioprinted constructs. Be a part of our mission to revolutionise the lives of millions with compromised organ function by advancing biofabricated tissue therapeutics. Help us enable longer and healthier lives of everyone. Ready to make a difference and for an exciting career step? Apply here: https://lnkd.in/eXNiWcue Let's create something extraordinary together! #JoinOurTeam #NowHiring #Cellbricks #JobOpening #3DBioprinting #Liver #OrganTransplantation #TissueTherapeutics